SK pharmteco Announces Successful FDA Inspection of Small Molecule Manufacturing Facility in La Porte, Texas

Contributed by: GlobeNewswire

Tags

SK pharmteco

More Like This

PR Newswire associated0

SK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023

SK pharmteco Unites Leading Brands to Create Global Powerhouse in CDMO Services

SK pharmteco Announces CGMP Qualification of its Commercial-Scale Viral Vector Manufacturing Facility in France

SK pharmteco Invests $260 Million to Expand Global Small Molecule and Peptide Production

SK pharmteco Reaffirms Three-Business-Unit Strategy, Strengthens Global Gene Therapy Business Unit with Funding Commitment

SK pharmteco Boosts Domestic Peptide Scale-Up with Investment in California Facility

SK pharmteco Embarks on Journey to Achieve My Green Lab Certification, Solidifying Commitment to Sustainable Laboratory Practices

SK pharmteco Achieves Highest-Level My Green Lab Certifications Across Europe and Asia